Gabriella Miller Kids First Training and Outreach Core (U24 Clinical Trials Not Allowed)
ID: 358960Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Small Businesses

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/358960
Timeline
    Description

    The National Institutes of Health (NIH) is announcing an upcoming funding opportunity for the Gabriella Miller Kids First Training and Outreach Core, aimed at enhancing pediatric research related to childhood cancer and congenital anomalies. This initiative seeks to engage researchers and patient communities to improve the utilization of Kids First data, ultimately leading to better-targeted therapies and interventions. The estimated total program funding is $800,000, with applications expected to be solicited in the future; interested parties are encouraged to prepare collaborative proposals. For further information, potential applicants can contact Concepcion R. Nierras, Ph.D., at 301-435-5840 or via email at concepcion.nierras@nih.gov.

    Point(s) of Contact
    Concepcion R. Nierras, Ph.D. Office of Strategic Coordination (OSC), DPCPSI, OD
    (301) 435-5840
    concepcion.nierras@nih.gov
    Files
    No associated files provided.
    Similar Opportunities
    Continued Development of the Gabriella Miller Kids First Pediatric Data Resource Center (U2C Clinical Trials Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is announcing a funding opportunity for the Continued Development of the Gabriella Miller Kids First Pediatric Data Resource Center through a Cooperative Agreement. This initiative aims to enhance the Pediatric Data Resource, focusing on expanding data sharing, providing training in cloud-based computational analysis, and facilitating data use for researchers with limited bioinformatics training, ultimately contributing to advancements in understanding childhood cancer and congenital anomalies. The estimated total program funding is $5,200,000, with applications not currently being solicited; however, potential applicants are encouraged to prepare collaborative projects in anticipation of the upcoming Notice of Funding Opportunity (NOFO), which is expected to be published by July 30, 2025, with a closing date for synopsis on October 30, 2025. For further inquiries, interested parties may contact Dr. Concepcion R. Nierras at 301-435-5840 or via email at concepcion.nierras@nih.gov.
    Genome Sequencing Center for the Gabriella Miller Kids First Pediatric Research Program (U24 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is set to announce a funding opportunity for the Genome Sequencing Center as part of the Gabriella Miller Kids First Pediatric Research Program, aimed at advancing research into childhood cancer and congenital anomalies. This initiative will support the addition of data to existing resources, enhance data types as technologies evolve, and incorporate clinic-based data sources to better understand the genetic pathways of these disorders. With an estimated total program funding of $6.6 million, this cooperative agreement does not require cost sharing and is open to small businesses. Interested applicants are encouraged to prepare for the upcoming Notice of Funding Opportunity (NOFO), with an estimated synopsis posting date of July 30, 2025, and a closing date of October 30, 2025. For further inquiries, potential applicants can contact Dr. Concepcion R. Nierras at 301-435-5840 or via email at concepcion.nierras@nih.gov.
    Small Research Grants for Analyses of Gabriella Miller Kids First Pediatric Research Data (R03 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering small research grants under the Gabriella Miller Kids First Pediatric Research Program, aimed at analyzing genomic and phenotypic data related to childhood cancers and structural birth defects. This funding opportunity encourages innovative research projects that utilize Kids First data, with a focus on developing analytical approaches, tools, or algorithms to enhance understanding and treatment of pediatric conditions. The initiative is part of a broader effort to leverage genomics for precision medicine in pediatric healthcare, with a maximum funding amount of $200,000 available for projects lasting up to two years. Interested applicants can find more information and apply by visiting the program's webpage or contacting NIH Grants Information at grantsinfo@nih.gov, with applications due by January 7, 2026.
    GREGoRi Data Coordination and Outreach Center (U01, Clinical Trials Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for the establishment of the GREGoRi Data Coordination and Outreach Center, aimed at advancing the Genomics Research to Elucidate the Genetics of Rare Disease (GREGoR) program. This initiative seeks to enhance the diagnosis of rare genetic disorders by developing innovative tools and analytical methods to identify causal genes and variants, with the center serving as the primary coordination hub for data and resources generated by the GREGoRi program. The total estimated funding for this cooperative agreement is $2 million, with one award anticipated, and applications are expected to be due in 2026 following the publication of the Notice of Funding Opportunity (NOFO) in 2025. For further inquiries, interested applicants can contact Lisa H. Chadwick at lisa.chadwick@nih.gov or by phone at 301-435-7275.
    Notice of Intent to Publish a Funding Opportunity Announcement for Institutional Network Award for Promoting Kidney, Urologic, and Hematologic Research Training (U2C - Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) for the Institutional Network Award aimed at promoting research training in kidney, urologic, and hematologic fields. This initiative seeks to support institutions in developing a robust network to engage and train the next generation of researchers through innovative outreach and career development activities, with each institution eligible to apply for a single award to support at least five trainee slots. The total estimated funding for this program is $4 million, with an award ceiling of $2.1 million, and the NIH anticipates making approximately eight awards. Interested applicants can reach out to Dr. Tracy Rankin at rankint@niddk.nih.gov or (301) 594-4748 for further information, with the estimated synopsis post date set for July 5, 2025, and applications expected to be solicited by October 5, 2025.
    Forecast for NINDS Child Neurologist Career Development Program (CNCDP) (K12 - Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is announcing the Forecast for the NINDS Child Neurologist Career Development Program (CNCDP), a federal grant opportunity aimed at enhancing the training of child neurologists to conduct research on neurological disorders in children. This program, utilizing the K12 activity code, seeks to support a national initiative overseen by a principal investigator and a national advisory committee, with a focus on fostering collaborations and developing impactful research projects. The estimated total funding for this program is $3,400,000, with one award anticipated, and applications are expected to be solicited starting June 27, 2025, with a closing date of September 19, 2025. For further inquiries, interested parties can contact Letitia Weigand, Ph.D., at letitia.weigand@nih.gov or by phone at 301-496-4188.
    Notice of Intent to Publish a Funding Opportunity Announcement for the Rare Diseases Clinical Research Consortia (RDCRC) for the Rare Diseases Clinical Research Network (RDCRN)
    National Institutes of Health
    The National Institutes of Health (NIH) plans to publish a Funding Opportunity Announcement (FOA) for the Rare Diseases Clinical Research Consortia (RDCRC) as part of the Rare Diseases Clinical Research Network (RDCRN). This initiative aims to enhance the diagnosis, management, and treatment of rare diseases through collaborative, multi-site, patient-centric research, with a focus on addressing unmet clinical trial readiness needs. The estimated total program funding for this opportunity is $1,000,000, with the FOA expected to be published in 2024 and applications due later that year. Interested applicants can reach out to Dr. Tiina K. Urv at 301-827-2746 or via email at urvtiin@mail.nih.gov for further information.
    Notice of Intent to Publish a Funding Opportunity Announcement for HIV Pediatric, Adolescent and Maternal Clinical Trials
    National Institutes of Health
    The National Institutes of Health (NIH) plans to publish a Notice of Funding Opportunity (NOFO) for research focused on high-priority HIV studies targeting infants, children, adolescents, young adults, and maternal populations. This initiative aims to establish an HIV clinical trials network dedicated to these demographics, fostering innovative and collaborative clinical trials to address significant research areas in HIV and related health issues. The estimated total program funding is $30 million, with two awards anticipated, and potential applicants are encouraged to begin forming collaborations and developing proposals ahead of the expected synopsis posting on November 21, 2025. For further inquiries, interested parties may contact Dr. Sonia Lee at Sonia.lee@nih.gov or by phone at 301-594-4783.
    Notice of Intent to Publish a Notice of Funding Opportunity (NOFO) for the Rare Diseases Clinical Research Consortia (RDCRC) for the Rare Diseases Clinical Research Network (RDCRN)
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) for the Rare Diseases Clinical Research Consortia (RDCRC) as part of the Rare Diseases Clinical Research Network (RDCRN). This initiative aims to solicit applications for collaborative, multi-site research focused on advancing the diagnosis, management, and treatment of rare diseases, with an emphasis on addressing unmet clinical trial readiness needs. The funding, estimated at $1 million, will support specialized centers through cooperative agreements, with the NOFO expected to be published in winter 2024 and applications due in summer 2024. Interested applicants should prepare to develop meaningful collaborations, as the estimated award date is set for July 1, 2025.
    Notice of Intent to Publish a Funding Opportunity Announcement for Data Management and Coordinating Center (DMCC) for Rare Diseases Clinical Research Network (RDCRN) (U2C Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) plans to publish a Funding Opportunity Announcement (FOA) for the establishment of a Data Management and Coordinating Center (DMCC) as part of the Rare Diseases Clinical Research Network (RDCRN). This initiative aims to enhance the diagnosis, management, and treatment of rare diseases by facilitating collaborative, multi-site, patient-centric research through the RDCRN and supporting the activities of the Rare Diseases Clinical Research Consortia (RDCRC). The estimated total program funding for this grant is $1,000,000, with the FOA expected to be published in 2024 and awards anticipated in 2025. Interested applicants can reach out to Dr. Tiina K. Urv at urvtiin@mail.nih.gov or by phone at 301-827-2746 for further information.